Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Neurology ; 45(3 Pt 1): 532-8, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7898711

RESUMO

In a prospective study, 17 Brazilian patients with parenchymatous neurocysticercosis were monitored for a period of 12 months after treatment with praziquantel. Taenia solium-specific IgG antibodies, interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha, neopterin, and soluble interleukin-2 receptor (sIL-2R) were measured in serum and CSF before starting the therapy, on the last day of treatment, 5 weeks after treatment, and 3, 6, and 12 months after treatment. The most common symptoms and signs found in patients before treatment were headache, neck stiffness, and seizures. Six months after commencement of therapy, 13 of the 17 patients were free of complaints. Clinical normalization was paralleled by a significant decrease (p < 0.05) in the amount of intrathecally produced anti-T solium IgG 1 year after treatment. IL-1 beta was undetectable in serum at all times, whereas in the CSF it was within the normal range during the whole study period. The mean concentration of sIL-2R in the CSF was 65 kU/l (normal, < 50 kU/l) 5 weeks after treatment, whereas in all subsequent investigations sIL-2R was undetectable. The median CSF neopterin level was slightly elevated before treatment (6.8 nmol/l). One year after treatment, it had dropped by 69% (p < 0.001) to a median value of 2.1 nmol/l. The size of planimetrically measured focal cystic brain lesions on CT correlated with the amount of intrathecally synthesized anti-T solium IgG at the end of the study (r = 0.89, p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Encefalopatias/tratamento farmacológico , Cisticercose/tratamento farmacológico , Praziquantel/uso terapêutico , Adolescente , Adulto , Anticorpos Anti-Helmínticos/sangue , Anticorpos Anti-Helmínticos/líquido cefalorraquidiano , Biopterinas/análogos & derivados , Biopterinas/sangue , Biopterinas/líquido cefalorraquidiano , Encefalopatias/imunologia , Criança , Cisticercose/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunoglobulina G/sangue , Imunoglobulina G/líquido cefalorraquidiano , Interleucina-1/sangue , Interleucina-1/líquido cefalorraquidiano , Masculino , Pessoa de Meia-Idade , Neopterina , Estudos Prospectivos , Receptores de Interleucina-2/análise
2.
Rev Soc Bras Med Trop ; 29(4): 373-6, 1996.
Artigo em Português | MEDLINE | ID: mdl-8768588

RESUMO

We relate a case of an 18-year-old man, resident of Xapuri (state of Acre, Brazil), with a history of repeated episodes of meningoencephalitis (three in one year), each one was examined by a local doctor. In our service (Emílio Ribas Institute of Infectology) we observed a patient with polyjoint aches, radiological and bronchoscopic pulmonary alterations (without clinical features), meningeal and brain stem manifestations--with normal brain computed tomography and cerebrospinal fluid. Blood eosinophils and serological Toxocara canis test (ELISA) were greatly increased. With the hypothesis of Toxocariasis (visceral larva migrans) we administered thiabendazole that brought complete clinical and laboratory remission. Inspite of a new episode of headache with meningeal manifestation approximately one month later (treated with dexamethasone resulting in a full remission after three days) we have not found other manifestations in approximately three and a half years of ambulatory care.


Assuntos
Larva Migrans Visceral/diagnóstico , Toxocara canis , Adolescente , Animais , Anticorpos Anti-Helmínticos/sangue , Antinematódeos/administração & dosagem , Brasil , Doença Crônica , Dexametasona/uso terapêutico , Glucocorticoides/uso terapêutico , Humanos , Larva Migrans Visceral/complicações , Larva Migrans Visceral/tratamento farmacológico , Masculino , Recidiva , Tiabendazol/administração & dosagem , Toxocara canis/imunologia
3.
Rev. Soc. Bras. Med. Trop ; 29(4): 373-6, Jul.-Aug. 1996. tab
Artigo em Português | LILACS | ID: lil-187159

RESUMO

We relate a case of an 18-year-old man, resident of Xapuri (state of Acre, Brazil), with a history of repeated episodes of meningoencephalitis (three in one year), each one was examined by a local doctor. In our service (Emílio Ribas Institute of Infectology) we observed a patient with polyjoint aches, radiological and bronchoscopic pulmonary alterations (without clinical features), meningeal and brain stem manifestations--with normal brain computed tomography and cerebrospinal fluid. Blood eosinophils and serological Toxocara canis test (ELISA) were greatly increased. With the hypothesis of Toxocariasis (visceral larva migrans) we administered thiabendazole that brought complete clinical and laboratory remission. Inspite of a new episode of headache with meningeal manifestation approximately one month later (treated with dexamethasone resulting in a full remission after three days) we have not found other manifestations in approximately three and a half years of ambulatory care.


Assuntos
Humanos , Animais , Masculino , Adolescente , Larva Migrans Visceral/diagnóstico , Toxocara canis , Anticorpos Anti-Helmínticos/sangue , Antinematódeos/administração & dosagem , Brasil , Doença Crônica , Dexametasona/uso terapêutico , Glucocorticoides/uso terapêutico , Larva Migrans Visceral/complicações , Larva Migrans Visceral/tratamento farmacológico , Recidiva , Tiabendazol/administração & dosagem , Toxocara canis/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA